LPS induces inflammatory responses in human aortic vascular smooth muscle cells via Toll-like receptor 4 expression and nitric oxide production

Immunology Letters

Volumn 120, Issue 1-2, 2008, Pages 57-64

  Heo, Sook Kyoung ^a   Yun, Hyun Jeong ^a   Noh, Eui Kyu ^b   Park, Won Hwan ^a   Park, Sun Dong ^a  

^a Dongguk University   (South Korea)

^b Ulsan University College of Medicine   (South Korea)

Author keywords

Anti inflammation; iNOS; LPS; NO; TLR4

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TOLL LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANTIBODIES, MONOCLONAL; AORTA; CELL LINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MYOCYTES, SMOOTH MUSCLE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TOLL-LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 50449089235     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.07.002     Document Type: Article

References (29)

1. Yang X., Coriolan D., Murthy V., Schultz K., Golenbock D.T., and Beasley D. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am J Physiol Heart Circ Physiol 289 (2005) H1069-H1076
2. Li H., He Y., Zhang J., Sun S., and Sun B. Lipopolysaccharide regulates Toll-like receptor 4 expression in human aortic smooth muscle cells. Cell Biol Int 31 (2007) 831-835
3. Rice J.B., Stoll L.L., Li W.G., Denning G.M., Weydert J., Charipar E., et al. Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arterioscler Thromb Vasc Biol. 23 (2003) 1576-1582
4. Frantz S., Ertl G., and Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 4 (2007) 444-454
5. Wiedermann C.J., Kiechl S., Dunzendorfer S., Schratzberger P., Egger G., Oberhollenzer F., et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 34 (1999) 1975-1981
6. Stoll L.L., Denning G.M., Li W.G., Rice J.B., Harrelson A.L., Romig S.A., et al. Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J Immunol 173 (2004) 1336-1343
7. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57 (1995) 791-804
8. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84 (2004) 767-801
9. Zhang H.S., and Wang S.Q. Ginsenoside Rg1 inhibits tumor necrosis factor-alpha (TNF-alpha)-induced human arterial smooth muscle cells (HASMCs) proliferation. J Cell Biochem 98 (2006) 1471-1481
10. Rakesh K., and Agrawal D.K. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int Immunopharmacol 5 (2005) 1487-1506
11. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., and Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 18 (1998) 842-851
12. Moiseeva E.P. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 52 (2001) 372-386
13. Galkina E., and Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27 (2007) 2292-2301
14. O'Brien K.D., Allen M.D., McDonald T.O., Chait A., Harlan J.M., Fishbein D., et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92 (1993) 945-951
15. Heo S.K., Ju S.A., Lee S.C., Park S.M., Choe S.Y., Kwon B., et al. LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM. J Leukoc Biol 79 (2006) 330-338
16. WAF1 mRNA in human colon cancer HT-29 cells treated with inositol hexaphosphate. Acta Biochim Pol 53 (2006) 349-356
17. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
18. Tipping P.G., and Hancock W.W. Production of tumor necrosis factor and interleukin-1 by macrophages from human atherosclerotic plaques. Am J Pathol 142 (1993) 1721-1728
19. Ikeda U., Ito T., and Shimada K. Interleukin-6 and acute coronary syndrome. Clin Cardiol 24 (2001) 701-704
20. Ikeda U., Matsui K., Murakami Y., and Shimada K. Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol 25 (2002) 143-147
21. Fan J., and Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 10 (2003) 63-71
22. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138 (1999) S419-S420
23. Chung C.P., Avalos I., Raggi P., and Stein C.M. Atherosclerosis and inflammation: insights from rheumatoid arthritis. Clin Rheumatol 26 (2007) 1228-1233
24. Pasterkamp G., Van Keulen J.K., and De Kleijn D.P. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 34 (2004) 328-334
25. Michelsen K.S., and Arditi M. Toll-like receptor signaling and atherosclerosis. Curr Opin Hematol 13 (2006) 163-168
26. Mullick A.E., Tobias P.S., and Curtiss L.K. Toll-like receptors and atherosclerosis: key contributors in disease and health?. Immunol Res 34 (2006) 193-209
27. Björkbacka H. Multiple roles of Toll-like receptor signaling in atherosclerosis. Curr Opin Lipidol 17 (2006) 527-533
28. Yan Z.Q., and Hansson G.K. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 219 (2007) 187-203
29. Lin F.Y., Chen Y.H., Chen Y.L., Wu T.C., Li C.Y., Chen J.W., et al. Ginkgo biloba extract inhibits endotoxin-induced human aortic smooth muscle cell proliferation via suppression of Toll-like receptor 4 expression and NADPH oxidase activation. Agric Food Chem 55 (2007) 1977-1984